Status:
RECRUITING
Real-world of AI in Diagnosing Retinal Diseases
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
Artificial Intelligence
Retinal Diseases
Eligibility:
All Genders
1-100 years
Brief Summary
The objective of this study is to apply an artificial intelligence algorithm to diagnose multi-retinal diseases in real-world settings. The effectiveness and accuracy of this algorithm are evaluated b...
Detailed Description
The objective of this study is to apply an artificial intelligence algorithm to diagnose referral diabetes retinopathy, referral age-related macular degeneration, referral possible glaucoma, pathologi...
Eligibility Criteria
Inclusion
- fundus photography around 45° field which covers optic disc and macula
- complete identification information
Exclusion
- insufficient information for diagnosis
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2029
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT05981950
Start Date
August 1 2023
End Date
August 1 2029
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wen-Bin Wei
Beijing, Beijing Municipality, China, 100730